This article is more than 5 years old. Information may no longer be current.
Top five articles from ESC
Click Here to Manage Email Alerts
The annual European Society of Cardiology Congress met Aug. 25-29, 2018, in Munich. Endocrine Today was there to cover breaking news and new research in cardiometabolic disorders. Below are the five most read articles from the meeting posted on Healio.com/Endocrinology:
PURE: Moderate red meat, dairy intake may help reduce mortality, CV risk
A new diet quality tool based on an analysis of more than 218,000 adults worldwide suggests that increased intake of unprocessed red meat, fish and whole fat dairy can reduce risk for all-cause mortality, MI and stroke, according to new data from the PURE study.
ASCEND: Aspirin, omega-3 supplements fail for primary prevention in diabetes
In a large cohort of patients with diabetes but no prior CVD, aspirin prevented vascular events but caused major bleeding events, and an omega-3 fatty acid supplement did not prevent vascular events, researchers from the ASCEND study reported.
No excess CV risk with lorcaserin for weight loss
Treatment with the serotonin receptor agonist lorcaserin yielded sustained weight loss over a median follow-up of 3 years without an excess risk for major adverse CV events in adults with overweight or obesity at high CV risk, according to new data from the CAMELLIA-TIMI 61 study.
Evolocumab shows CV benefit in metabolic syndrome
Adults with metabolic syndrome assigned to treatment with the PCSK9 inhibitor evolocumab experienced a greater absolute risk reduction for CV events vs. those without metabolic syndrome assigned to the therapy, with an even greater benefit seen in patients without diabetes.
Very high HDL raises risk for MI, death
In a new study, patients with HDL levels greater than 60 mg/dL had a nearly 50% increased risk for all-cause mortality, CV mortality and MI compared with HDL levels of 41 to 60 mg/dL.